GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,698 | -791 | -822 | -3,495 | -4,636 |
| Depreciation Amortization | 827 | 177 | 282 | 412 | 443 |
| Accounts receivable | 22 | -63 | -39 | 353 | 567 |
| Accounts payable and accrued liabilities | -118 | 288 | -268 | -39 | -501 |
| Other Working Capital | 499 | 291 | -468 | 644 | 233 |
| Other Operating Activity | 426 | -131 | 307 | 700 | 7 |
| Operating Cash Flow | $-1,042 | $-229 | $-1,008 | $-1,425 | $-3,887 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -47 | -13 | -6 | -11 | -160 |
| Sale Of Investment | N/A | 62 | N/A | 19 | N/A |
| Purchase Sale Intangibles | -262 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -262 | -147 | -174 | -164 | -143 |
| Investing Cash Flow | $-309 | $-98 | $-180 | $-156 | $-303 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,686 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -212 | -40 |
| Common Stock Issued | 4,006 | 247 | N/A | N/A | 5,868 |
| Other Financing Activity | 0 | 0 | 1,406 | 0 | -361 |
| Financing Cash Flow | $5,692 | $247 | $1,406 | $-212 | $5,467 |
| Exchange Rate Effect | -26 | 28 | -15 | -45 | -7 |
| Beginning Cash Position | 372 | 424 | 221 | 2,059 | 789 |
| End Cash Position | 4,687 | 372 | 424 | 221 | 2,059 |
| Net Cash Flow | $4,315 | $-52 | $203 | $-1,838 | $1,270 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,042 | -229 | -1,008 | -1,425 | -3,887 |
| Capital Expenditure | -47 | -13 | -6 | -11 | -160 |
| Free Cash Flow | -1,089 | -242 | -1,014 | -1,436 | -4,047 |